Loading provider…
Loading provider…
Infectious Disease Physician in Philadelphia, PA
NPI: 1386676740Primary Practice Location
HOSPITAL OF UNIV OF PENNSYLVANIA
3400 Spruce St, Philadelphia, PA
Primary Employer
University of Penn-Medical Group
pathology.med.upenn.edu
HQ Phone
Get MD Ian's Phone Numberphone_androidMobile
Get MD Ian's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 41 | 77 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 23 | 23 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 18 | 51 |
| 4 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 15 | 22 |
Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.
Authors: Jack Stapleton, Shawn Hassler, Paul Goepfert
Publication Date: 2014-09-23
HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic.
Authors: Joanne Stekler, Roy Gulick, Timothy Wilkin, Raphael Landovitz
Journal: J Infect Dis
Lead Sponsor: Eli Lilly and Company
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID), AbCellera Biologics Inc., Shanghai Junshi Bioscience Co., Ltd.
Intervention / Treatment: DRUG: Placebo, DRUG: Etesevimab, DRUG: Bamlanivimab